南非2013-2015年流感免疫重点风险人群的经济负担
该研究基于南非2013-2015年实验室确诊流感监测和成本核算数据,估算6-59月龄儿童、5-64岁HIV/PTB/基础疾病患者、孕妇及≥65岁人群的流感经济负担。结果显示这些风险人群占流感总成本的52.1%、重症就医成本的89.3%和寿命损失年的86.0%,为免疫规划成本效果分析提供基础。
要点
- 风险人群占流感总经济负担52.1%,重症就医成本占89.3%。
- 风险人群寿命损失年占流感相关死亡总YLL的86.0%。
- 结果为流感免疫规划成本效果研究提供依据。
核心结论
- 南非严重流感风险人群约占流感总成本一半,但占重症就医成本和YLL绝大部分。
研究设计与样本
- 利用2013-2015年实验室确诊流感监测和成本核算研究数据,从卫生系统和社会角度估算成本与YLL。
主要发现
- 风险人群YLL占流感相关死亡总YLL的86.0%(262,069/304,867年)。
临床怎么用
- 可将流感免疫资源优先投向严重流感风险人群,以降低重症就医成本和早死负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on influenza economic burden in risk groups for severe influenza are important to guide targeted influenza immunization, especially in resource-limited settings. However, this information is limited in low- and middle-income countries. METHODS: We estimated the cost (from a health system and societal perspective) and years of life lost (YLL) for influenza-associated illness in South Africa during 2013-2015 among (i) children aged 6-59 months, (ii) individuals aged 5-64 years with HIV, pulmonary tuberculosis (PTB) and selected underlying medical conditions (UMC), separately, (iii) pregnant women and (iv) individuals aged ≥65 years, using publicly available data and data collected through laboratory-confirmed influenza surveillance and costing studies. All costs were expressed in 2015 prices using the South Africa all-items Consumer Price Index. RESULTS: During 2013-2015, the mean annual cost of influenza-associated illness among the selected risk groups accounted for 52.1% ($140.9/$270.5 million) of the total influenza-associated illness cost (for the entire population of South Africa), 45.2% ($52.2/$115.5 million) of non-medically attended illness costs, 43.3% ($46.7/$107.9 million) of medically-attended mild illness costs and 89.3% ($42.0/$47.1 million) of medically-attended severe illness costs. The YLL among the selected risk groups accounted for 86.0% (262,069 /304,867 years) of the total YLL due to influenza-associated death. CONCLUSION: In South Africa, individuals in risk groups for severe influenza accounted for approximately half of the total influenza-associated illness cost but most of the cost of influenza-associated medically attended severe illness and YLL. This study provides the foundation for future studies on the cost-effectiveness of influenza immunization among risk groups.
引用
- Tempia S, Moyes J, Cohen AL, et al. Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020. PMID: 32980198. doi:10.1016/j.vaccine.2020.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。